{"id":"scopolamine-butylbromide","rwe":[],"tags":[{"label":"butylscopolamine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Muscarinic acetylcholine receptor M1","category":"target"},{"label":"CHRM1","category":"gene"},{"label":"CHRM2","category":"gene"},{"label":"CHRM3","category":"gene"},{"label":"A03BB01","category":"atc"},{"label":"Active","category":"status"},{"label":"Gastric spasm","category":"indication"},{"label":"Cholinergic Agents","category":"pharmacology"},{"label":"Cholinergic Antagonists","category":"pharmacology"},{"label":"Muscarinic Antagonists","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"},{"label":"Parasympatholytics","category":"pharmacology"},{"label":"Peripheral Nervous System Agents","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":199.755,"date":"","count":296,"signal":"Abdominal pain","source":"DrugCentral FAERS","actionTaken":"Reported 296 times (LLR=200)"},{"llr":74.476,"date":"","count":61,"signal":"Swollen tongue","source":"DrugCentral FAERS","actionTaken":"Reported 61 times (LLR=74)"},{"llr":68.511,"date":"","count":164,"signal":"Constipation","source":"DrugCentral FAERS","actionTaken":"Reported 164 times (LLR=69)"},{"llr":64.893,"date":"","count":272,"signal":"Vomiting","source":"DrugCentral FAERS","actionTaken":"Reported 272 times (LLR=65)"},{"llr":63.777,"date":"","count":72,"signal":"Swelling face","source":"DrugCentral FAERS","actionTaken":"Reported 72 times (LLR=64)"},{"llr":57.133,"date":"","count":50,"signal":"Colitis ulcerative","source":"DrugCentral FAERS","actionTaken":"Reported 50 times (LLR=57)"},{"llr":50.726,"date":"","count":317,"signal":"Diarrhoea","source":"DrugCentral FAERS","actionTaken":"Reported 317 times (LLR=51)"},{"llr":49.8,"date":"","count":31,"signal":"Lymphoedema","source":"DrugCentral FAERS","actionTaken":"Reported 31 times (LLR=50)"},{"llr":41.585,"date":"","count":14,"signal":"Acarodermatitis","source":"DrugCentral FAERS","actionTaken":"Reported 14 times (LLR=42)"},{"llr":39.844,"date":"","count":57,"signal":"Angioedema","source":"DrugCentral FAERS","actionTaken":"Reported 57 times (LLR=40)"},{"llr":37.089,"date":"","count":50,"signal":"Dysphonia","source":"DrugCentral FAERS","actionTaken":"Reported 50 times (LLR=37)"},{"llr":36.189,"date":"","count":55,"signal":"Colitis","source":"DrugCentral FAERS","actionTaken":"Reported 55 times (LLR=36)"},{"llr":35.305,"date":"","count":9,"signal":"External auditory canal atresia","source":"DrugCentral FAERS","actionTaken":"Reported 9 times (LLR=35)"},{"llr":34.975,"date":"","count":25,"signal":"Enterocolitis","source":"DrugCentral FAERS","actionTaken":"Reported 25 times (LLR=35)"},{"llr":34.924,"date":"","count":28,"signal":"Hydronephrosis","source":"DrugCentral FAERS","actionTaken":"Reported 28 times (LLR=35)"}],"commonSideEffects":[{"effect":"Transient tachycardia","drugRate":"","severity":"transient","organSystem":""},{"effect":"Decreased borborygmal sounds","drugRate":"","severity":"transient","organSystem":""},{"effect":"Transient pupillary dilation","drugRate":"","severity":"transient","organSystem":""}],"seriousAdverseEvents":[]},"trials":[],"aliases":[],"patents":[],"pricing":[{"market":"United States","source":"CMS National Average Drug Acquisition Cost (NADAC)","asOfDate":"2024-01-03","unitCost":"$6.8223/EA","priceType":"NADAC","sourceUrl":"https://data.medicaid.gov/dataset/4j6z-xnwq","annualCost":"$2,490","description":"SCOPOLAMINE 1 MG/3 DAY PATCH","retrievedDate":"2026-04-07"}],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=scopolamine butylbromide","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:56:42.008568+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:56:48.222195+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=scopolamine butylbromide","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:56:48.576568+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1618102/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:56:49.281211+00:00"}},"allNames":"buscopan","offLabel":[],"synonyms":["buscopan","scopolamine butyl hydroxide","scopolamine butylbromide","hyoscine butylbromide","butylscopolamine","butylscopolammonium","butylscopolamine bromide","n-butylscopolammonium","n-butylscopolammonium bromide"],"timeline":[{"date":"1951-01-01","type":"positive","source":"DrugCentral","milestone":"YEAR INTRODUCED approval"}],"approvals":[{"date":"1951-01-01","orphan":false,"company":"","regulator":"YEAR INTRODUCED"}],"brandName":"Buscopan","ecosystem":[{"indication":"Gastric spasm","otherDrugs":[],"globalPrevalence":null}],"mechanism":{"target":"Muscarinic acetylcholine receptor M1","targets":[{"gene":"CHRM1","source":"DrugCentral","target":"Muscarinic acetylcholine receptor M1","protein":"Muscarinic acetylcholine receptor M1"},{"gene":"CHRM2","source":"DrugCentral","target":"Muscarinic acetylcholine receptor M2","protein":"Muscarinic acetylcholine receptor M2"},{"gene":"CHRM3","source":"DrugCentral","target":"Muscarinic acetylcholine receptor M3","protein":"Muscarinic acetylcholine receptor M3"},{"gene":"CHRM4","source":"DrugCentral","target":"Muscarinic acetylcholine receptor M4","protein":"Muscarinic acetylcholine receptor M4"}],"modality":"Small Molecule","drugClass":"butylscopolamine","explanation":"","oneSentence":"","technicalDetail":"Buscopan exerts its effects by competitively antagonizing the muscarinic acetylcholine receptor M1, thereby inhibiting the parasympathetic stimulation of gastric smooth muscle contractions."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/458","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=scopolamine%20butylbromide","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=scopolamine butylbromide","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:35:43.298300","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:56:50.837852+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"methscopolamine","drugSlug":"methscopolamine","fdaApproval":"1953-04-09","genericCount":5,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"methylhomatropine","drugSlug":"methylhomatropine","fdaApproval":"1943-03-23","relationship":"same-class"}],"dataSources":[{"url":"https://data.medicaid.gov/dataset/4j6z-xnwq","name":"CMS National Average Drug Acquisition Cost (NADAC)","fields":["pricing"],"retrievedDate":"2026-04-07"}],"genericName":"scopolamine butylbromide","indications":{"approved":[{"name":"Gastric spasm","source":"DrugCentral","snomedId":196754001,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"methscopolamine","brandName":"methscopolamine","genericName":"methscopolamine","approvalYear":"1953","relationship":"same-class"},{"drugId":"methylhomatropine","brandName":"methylhomatropine","genericName":"methylhomatropine","approvalYear":"1943","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07474350","phase":"NA","title":"Valethamate Bromide Versus Hyoscine Butyl Bromide in Reducing Labour Duration Among Primigravida","status":"COMPLETED","sponsor":"Federal Teaching Hospital Abakaliki","startDate":"2023-09-01","conditions":["Labour Duration","Primigravida"],"enrollment":165,"completionDate":"2024-01-23"},{"nctId":"NCT07267130","phase":"PHASE1","title":"A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects","status":"RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.","startDate":"2025-11-25","conditions":["Chronic Obstructive Pulmonary Disease"],"enrollment":57,"completionDate":"2026-12"},{"nctId":"NCT07423923","phase":"EARLY_PHASE1","title":"Representation of Spatiotemporal Information in Human Episodic Memory and Navigation","status":"ENROLLING_BY_INVITATION","sponsor":"University of Arizona","startDate":"2025-05-01","conditions":["Scopolamine or Placebo","Schema to Organize Memory or no Schema"],"enrollment":15,"completionDate":"2030-04-30"},{"nctId":"NCT07383571","phase":"NA","title":"Oral Hyoscine vs. Topical EMLA vs. Placebo for Pain Reduction During Hysterosalpingography","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-10-03","conditions":["Hysterosalpingography"],"enrollment":102,"completionDate":"2026-03-30"},{"nctId":"NCT03616067","phase":"PHASE3","title":"Evaluation of the Efficacy of the Injection of Botulinum Toxin A vs Scopolamine Patches in the Treatment of Drooling in Children With Cerebral Palsy","status":"TERMINATED","sponsor":"Hospices Civils de Lyon","startDate":"2022-04-27","conditions":["Cerebral Palsy"],"enrollment":23,"completionDate":"2025-09-22"},{"nctId":"NCT07271303","phase":"NA","title":"A Clinical Study to Evaluate the Efficacy and Safety of Hyoscine Butylbromide Capsules for Preoperative Preparation in Painless Gastrointestinal Endoscopy Procedures","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2026-02-01","conditions":["Painless Gastrointestinal Endoscopy"],"enrollment":74,"completionDate":"2026-12-01"},{"nctId":"NCT04990167","phase":"PHASE2","title":"Tiotropium vs. Inhaled Corticosteroids in Children With Nonatopic Asthma Pilot Study (TioNAAP)","status":"TERMINATED","sponsor":"Nemours Children's Clinic","startDate":"2022-01-01","conditions":["Asthma in Children"],"enrollment":11,"completionDate":"2025-10-31"},{"nctId":"NCT03246581","phase":"PHASE1","title":"Two-period 21 Day Cross-over Study to Compare the Pharmacokinetics of Tiotropium From Two Inhalers","status":"COMPLETED","sponsor":"Kindeva Drug Delivery","startDate":"2017-07-13","conditions":["Healthy"],"enrollment":40,"completionDate":"2018-05-03"},{"nctId":"NCT03270839","phase":"PHASE4","title":"Motion Sickness Medications and Vestibular Time Constant","status":"COMPLETED","sponsor":"Medical Corps, Israel Defense Force","startDate":"2017-06-01","conditions":["Drug Reaction"],"enrollment":54,"completionDate":"2020-01-01"},{"nctId":"NCT05594017","phase":"EARLY_PHASE1","title":"Pharmacological Modulation of Brain Oscillations in Memory Processing","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2019-08-01","conditions":["Epilepsy","Seizures","Cognitive Impairment, Mild","Memory Disorders","Memory Loss"],"enrollment":60,"completionDate":"2027-05-31"},{"nctId":"NCT04993508","phase":"NA","title":"Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Combination of PSA/DRE and Multi Parametric Magnetic Resonance Imaging","status":"NOT_YET_RECRUITING","sponsor":"Heinrich-Heine University, Duesseldorf","startDate":"2026-04-01","conditions":["Prostate Cancer"],"enrollment":1908,"completionDate":"2030-03-31"},{"nctId":"NCT04756232","phase":"EARLY_PHASE1","title":"Cholinergic Mechanisms of Attention in Aging","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2022-04-21","conditions":["Subjective Cognitive Decline"],"enrollment":19,"completionDate":"2025-05-01"},{"nctId":"NCT04999449","phase":"PHASE1","title":"Nebulizer Delivery of Intranasal Scopolamine","status":"COMPLETED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2022-01-24","conditions":["Scopolamine","Motion Sickness"],"enrollment":14,"completionDate":"2025-05-07"},{"nctId":"NCT06282861","phase":"PHASE4","title":"ANTES B+ Clinical Trial","status":"TERMINATED","sponsor":"Fundacio Privada Mon Clinic Barcelona","startDate":"2024-02-29","conditions":["Chronic Obstructive Pulmonary Disease"],"enrollment":48,"completionDate":"2025-01-23"},{"nctId":"NCT04240626","phase":"PHASE4","title":"Multimodal Analgesia Effect on Post Surgical Patient","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Davis","startDate":"2021-01-20","conditions":["Obesity, Morbid","Surgery","Bariatric Surgery Candidate"],"enrollment":60,"completionDate":"2026-06-24"},{"nctId":"NCT06938581","phase":"NA","title":"ERAS Protocols in Breast Conserving Surgery","status":"RECRUITING","sponsor":"University of Nebraska","startDate":"2025-07-11","conditions":["Breast Cancer","Postoperative Recovery"],"enrollment":260,"completionDate":"2029-02"},{"nctId":"NCT04366518","phase":"EARLY_PHASE1","title":"Toward a Computationally-Informed, Personalized Treatment for Hallucinations","status":"RECRUITING","sponsor":"Yale University","startDate":"2021-07-15","conditions":["Hallucinations, Auditory","Psychosis"],"enrollment":35,"completionDate":"2032-08"},{"nctId":"NCT05634057","phase":"NA","title":"Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis","status":"RECRUITING","sponsor":"Chen Ying","startDate":"2024-01-25","conditions":["Sepsis"],"enrollment":782,"completionDate":"2025-12"},{"nctId":"NCT06014385","phase":"PHASE1","title":"PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor","status":"WITHDRAWN","sponsor":"Yale University","startDate":"2025-03","conditions":["Muscarinic Receptor Occupancy"],"enrollment":0,"completionDate":"2025-07-01"},{"nctId":"NCT05260320","phase":"NA","title":"Anesthetic Optimization in Pediatric LeFort Surgeries","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-05-02","conditions":["Le Fort","Pain, Postoperative"],"enrollment":50,"completionDate":"2027-07"},{"nctId":"NCT04211961","phase":"PHASE2","title":"Scopolamine in Bipolar Depression","status":"COMPLETED","sponsor":"Dr. Brian Hallahan","startDate":"2021-03-23","conditions":["Bipolar Disorder Depression"],"enrollment":55,"completionDate":"2024-02-22"},{"nctId":"NCT02202369","phase":"PHASE4","title":"Multimodal Analgesia vs. Routine Care Pain Management for Lumbar Spine Fusion Surgery: A Prospective Randomized Study","status":"SUSPENDED","sponsor":"OrthoCarolina Research Institute, Inc.","startDate":"2015-06-25","conditions":["Single Level Lumbar Decompression and Fusion Spine Surgery"],"enrollment":50,"completionDate":"2050-12-31"},{"nctId":"NCT06927817","phase":"PHASE4","title":"The Effect of Hyoscine-n-butylbromide on Nausea and Pain in Laparoscopic Cholecystectomy","status":"COMPLETED","sponsor":"Saglik Bilimleri Universitesi","startDate":"2020-11-15","conditions":["Cholecystitis","Pain","Nausea"],"enrollment":134,"completionDate":"2025-04-08"},{"nctId":"NCT05506865","phase":"PHASE4","title":"Efficacy and Safety of Indacaterol vs Tiotropium in Women With COPD Secondary to Biomass Exposure","status":"COMPLETED","sponsor":"National Institute of Respiratory Diseases, Mexico","startDate":"2012-09","conditions":["COPD"],"enrollment":73,"completionDate":"2016-07"},{"nctId":"NCT05362487","phase":"","title":"Assessment of Health-related Quality of Life After Switching COPD Patients From a Dry Powder Inhaler to a Soft Mist Inhaler Remaining on the Same Inhalative Drug","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2022-08-05","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":9,"completionDate":"2023-01-18"},{"nctId":"NCT04314713","phase":"PHASE1","title":"A Study to Evaluate the Intramuscular Administration of Scopolamine","status":"TERMINATED","sponsor":"Battelle Memorial Institute","startDate":"2020-06-02","conditions":["Medical Countermeasures","Organophosphate Poisoning"],"enrollment":32,"completionDate":"2021-05-06"},{"nctId":"NCT02175342","phase":"PHASE2","title":"Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"1998-03-01","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":202,"completionDate":""},{"nctId":"NCT05165485","phase":"PHASE4","title":"Phase 4 COPD and Suboptimal Inspiratory Flow Rate","status":"COMPLETED","sponsor":"Theravance Biopharma","startDate":"2022-01-07","conditions":["Chronic Obstructive Pulmonary Disease"],"enrollment":404,"completionDate":"2023-11-20"},{"nctId":"NCT01152450","phase":"PHASE2","title":"A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent Asthma","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2010-07","conditions":["Asthma"],"enrollment":94,"completionDate":""},{"nctId":"NCT02627625","phase":"PHASE1","title":"Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Two Reference Products","status":"COMPLETED","sponsor":"Solventum US LLC","startDate":"2015-11","conditions":["Healthy"],"enrollment":31,"completionDate":"2016-06"},{"nctId":"NCT02676297","phase":"PHASE1","title":"Cross-over Study in Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Test and Reference Products","status":"COMPLETED","sponsor":"Solventum US LLC","startDate":"2016-01","conditions":["Healthy"],"enrollment":26,"completionDate":"2016-07"},{"nctId":"NCT03302065","phase":"PHASE1","title":"Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Reference","status":"COMPLETED","sponsor":"Solventum US LLC","startDate":"2016-05","conditions":["Healthy"],"enrollment":38,"completionDate":"2017-01"},{"nctId":"NCT04081545","phase":"PHASE3","title":"Effect of Opioid Free Anesthetic on Post-Operative Opioid Consumption After Laparoscopic Bariatric Surgery","status":"COMPLETED","sponsor":"Christine Oryhan","startDate":"2019-12-24","conditions":["Opioid Use, Unspecified","Bariatric Surgery Candidate","Anesthesia"],"enrollment":181,"completionDate":"2023-06-30"},{"nctId":"NCT06679465","phase":"PHASE4","title":"Evaluating the Impact of Single Dose Tiotropium on Allergen-induced Early Asthmatic Response","status":"NOT_YET_RECRUITING","sponsor":"University of Saskatchewan","startDate":"2025-01-01","conditions":["Asthma Bronchiale"],"enrollment":10,"completionDate":"2027-01"},{"nctId":"NCT04061161","phase":"PHASE4","title":"Anti-inflammatory Effects of Tiotropium in Patients with Stable COPD","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2019-08-19","conditions":["COPD"],"enrollment":37,"completionDate":"2023-12-31"},{"nctId":"NCT03199976","phase":"PHASE4","title":"Efficacy of Intermittent Tiotropium in Early Childhood Wheezing","status":"TERMINATED","sponsor":"Helsinki University Central Hospital","startDate":"2016-04-20","conditions":["Wheezy Bronchitis","Asthmatic Bronchitis","Wheezing","Obstruction Airway"],"enrollment":80,"completionDate":"2020-11-18"},{"nctId":"NCT05402020","phase":"","title":"Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2022-09-30","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":17018,"completionDate":"2023-02-13"},{"nctId":"NCT06525051","phase":"","title":"Effect of Tiotropium on Eye Findings in the Treatment of Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Giresun University","startDate":"2023-10-23","conditions":["Chronic Obstructive Pulmonary Disease","Glaucoma, Angle-Closure"],"enrollment":108,"completionDate":"2024-04-30"},{"nctId":"NCT04672941","phase":"","title":"Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients After Switching to Tiotropium Plus Olodaterol Fixed Dose Combination in Greece","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2021-02-16","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":1396,"completionDate":"2022-02-21"},{"nctId":"NCT05886660","phase":"PHASE2","title":"Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance","status":"RECRUITING","sponsor":"Repurposed Therapeutics, Inc.","startDate":"2022-01-21","conditions":["Motion Sickness, Space","Motion Sickness","Sea Sickness"],"enrollment":30,"completionDate":"2024-09"},{"nctId":"NCT05852730","phase":"PHASE2","title":"Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance","status":"RECRUITING","sponsor":"Repurposed Therapeutics, Inc.","startDate":"2021-08-10","conditions":["Motion Sickness, Space","Motion Simulation","Parabolic Flight"],"enrollment":80,"completionDate":"2026-09"},{"nctId":"NCT04823065","phase":"PHASE1,PHASE2","title":"4FMFES-PET Imaging of Endometrial and Ovarian Cancers","status":"COMPLETED","sponsor":"Centre de recherche du Centre hospitalier universitaire de Sherbrooke","startDate":"2018-09-01","conditions":["Endometrial Cancer","Ovarian Cancer"],"enrollment":53,"completionDate":"2024-04-30"},{"nctId":"NCT06398054","phase":"PHASE4","title":"A Study to Investigate the Analgesic Efficacy of Ibuprofen Alone and Ibuprofen Plus Hyoscine-n- Butyl Bromide in Reducing Pain of Outpatient Hysteroscopy","status":"NOT_YET_RECRUITING","sponsor":"ASST Fatebenefratelli Sacco","startDate":"2024-10-01","conditions":["Pain"],"enrollment":190,"completionDate":"2026-10-01"},{"nctId":"NCT05021263","phase":"PHASE3","title":"Does IV Magnesium Improve Quality of Recovery With ERAS Protocols in Laparoscopic Colorectal Surgery?","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2022-05-27","conditions":["Colo-rectal Cancer","Anesthesia"],"enrollment":90,"completionDate":"2023-12-29"},{"nctId":"NCT05719467","phase":"PHASE3","title":"SAINT: Safe Induction of Labor Trial","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2023-01-03","conditions":["Labor Complication","Induced; Birth","Pregnancy Related"],"enrollment":3000,"completionDate":"2027-12-31"},{"nctId":"NCT05501639","phase":"","title":"Exacerbation Risk in Asthma","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2021-05-14","conditions":["Asthma"],"enrollment":1899,"completionDate":"2021-11-02"},{"nctId":"NCT03435003","phase":"PHASE4","title":"Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy","status":"COMPLETED","sponsor":"Stony Brook University","startDate":"2017-08-28","conditions":["Post-operative Nausea and Vomiting","Laparoscopic Sleeve Gastrectomy"],"enrollment":83,"completionDate":"2019-04-01"},{"nctId":"NCT06254664","phase":"PHASE1","title":"Open Label Study to Assess the Effect of Patient Use and Robustness of Tiotropium 18ug Inhalation Powder, Hard Capsule,Zephir Inhaler Device","status":"COMPLETED","sponsor":"Xiromed LLC","startDate":"2022-10-03","conditions":["COPD"],"enrollment":116,"completionDate":"2023-10-27"},{"nctId":"NCT05986591","phase":"PHASE3","title":"Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Xiromed LLC","startDate":"2022-08-17","conditions":["COPD"],"enrollment":335,"completionDate":"2023-08-14"},{"nctId":"NCT05939635","phase":"NA","title":"M-Tapa Block vs External Oblique Intercostal Block for Laparoscopic Sleeve Gastrectomy Surgery","status":"COMPLETED","sponsor":"Ondokuz Mayıs University","startDate":"2023-07-11","conditions":["Anesthesia","Regional Anesthesia","Postoperative Pain"],"enrollment":66,"completionDate":"2024-01-29"},{"nctId":"NCT06207539","phase":"EARLY_PHASE1","title":"Induction of Abortion in the Second Trimester","status":"COMPLETED","sponsor":"Ain Shams Maternity Hospital","startDate":"2022-12-01","conditions":["Abortion, Second Trimester"],"enrollment":40,"completionDate":"2023-04-30"},{"nctId":"NCT02515474","phase":"NA","title":"Comparison of LCBDE vs ERCP + LC for Choledocholithiasis","status":"COMPLETED","sponsor":"Hepatopancreatobiliary Surgery Institute of Gansu Province","startDate":"2015-09-01","conditions":["Choledocholithiasis"],"enrollment":1000,"completionDate":"2024-01-01"},{"nctId":"NCT00144196","phase":"PHASE4","title":"12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2004-03-11","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":224,"completionDate":"2005-07-25"},{"nctId":"NCT00274560","phase":"PHASE3","title":"A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2002-05-01","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":653,"completionDate":""},{"nctId":"NCT00274508","phase":"PHASE3","title":"Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2000-10-10","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":261,"completionDate":""},{"nctId":"NCT00239447","phase":"PHASE3","title":"Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2002-11-26","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":131,"completionDate":"2004-04-29"},{"nctId":"NCT00388882","phase":"PHASE4","title":"Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2006-10-04","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":327,"completionDate":""},{"nctId":"NCT02242266","phase":"PHASE2","title":"Pharmacokinetics and Safety Comparison of Tiotropium Inhalation Powder Administered as the Bromide Salt From Hard Polyethylene Capsule Via the HandiHaler® 2 and Spiriva® HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2005-07-28","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":121,"completionDate":""},{"nctId":"NCT05127304","phase":"","title":"A Study Using US Medical and Pharmacy Claim Records to Compare the Resource Use, Cost, and Outcomes of People With COPD Who Take Either Tiotropium + Olodaterol or Fluticasone + Umeclidinium + Vilanterol","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2021-02-26","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":11316,"completionDate":"2022-02-03"},{"nctId":"NCT00668772","phase":"PHASE3","title":"Tiotropium/Salmeterol Inhalation Powder in COPD","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2008-04-15","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":207,"completionDate":"2008-11-21"},{"nctId":"NCT05169424","phase":"","title":"A Study in the US Based on Pharmacy and Medical Claims That Compares How Well Stiolto® and Trelegy® Work in People With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2021-12-17","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":9117,"completionDate":"2021-12-27"},{"nctId":"NCT06056869","phase":"NA","title":"Effect of Hyoscine- Bromide on Duration of the First Stage of Labor","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2023-09-27","conditions":["Labor"],"enrollment":60,"completionDate":"2024-04"},{"nctId":"NCT04666701","phase":"PHASE2","title":"Efficacy and Safety of Escócia Association in the Treatment of Acute Pain","status":"WITHDRAWN","sponsor":"EMS","startDate":"2023-02","conditions":["Acute Pain"],"enrollment":0,"completionDate":"2025-06"},{"nctId":"NCT00662740","phase":"PHASE3","title":"Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD)","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2008-04-15","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":220,"completionDate":"2008-11-21"},{"nctId":"NCT05179512","phase":"","title":"Replication of the INSPIRE Trial in Healthcare Claims Data","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2020-09-22","conditions":["Chronic Obstructive Pulmonary Disease"],"enrollment":98278,"completionDate":"2021-08-30"},{"nctId":"NCT05083429","phase":"","title":"Replication of the POET-COPD Trial in Healthcare Claims Data","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2020-09-22","conditions":["Chronic Obstructive Pulmonary Disease"],"enrollment":8716,"completionDate":"2021-08-09"},{"nctId":"NCT02849639","phase":"EARLY_PHASE1","title":"The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression","status":"COMPLETED","sponsor":"Daniela Moga","startDate":"2017-04-04","conditions":["Alzheimer's Disease","Dementia"],"enrollment":90,"completionDate":"2021-04-21"},{"nctId":"NCT05927155","phase":"PHASE3","title":"Effects of Acute Long-acting Bronchodilation on Oxygenation and Peripheral Ventilation in COPD","status":"COMPLETED","sponsor":"Erasme University Hospital","startDate":"2021-06-15","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":30,"completionDate":"2022-03-30"},{"nctId":"NCT05913310","phase":"PHASE4","title":"Efficacy and Safety of Kui-Yuan Chewable Tablets in Patients With Hyperuricemia","status":"UNKNOWN","sponsor":"Quan Jiang","startDate":"2023-07","conditions":["Hyperuricemia"],"enrollment":126,"completionDate":"2024-08"},{"nctId":"NCT05911126","phase":"NA","title":"How to Reduce Pain in Patients Undergoing Office Hysteroscopy.","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-06-13","conditions":["Pain"],"enrollment":180,"completionDate":"2023-12-13"},{"nctId":"NCT03332056","phase":"PHASE4","title":"The Use of Belladonna and Opium Suppository in the Treatment of Postoperative Stent Pain","status":"COMPLETED","sponsor":"University of Washington","startDate":"2013-08","conditions":["Nephrolithiasis"],"enrollment":71,"completionDate":"2015-10"},{"nctId":"NCT05838703","phase":"PHASE2","title":"Tiotropium Handihaler vs. Tiotropium Respimat in COPD","status":"WITHDRAWN","sponsor":"Duke University","startDate":"2023-05-01","conditions":["Chronic Obstructive Pulmonary Disease (COPD)"],"enrollment":0,"completionDate":"2024-05-01"},{"nctId":"NCT03988530","phase":"PHASE3","title":"Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects","status":"COMPLETED","sponsor":"Repurposed Therapeutics, Inc.","startDate":"2019-06-07","conditions":["Motion Sickness"],"enrollment":98,"completionDate":"2020-11-23"},{"nctId":"NCT05161156","phase":"PHASE3","title":"Bioequivalence Study of Tiotropium Bromide Inhalation Powder","status":"COMPLETED","sponsor":"Phargentis SA","startDate":"2022-03-24","conditions":["COPD"],"enrollment":306,"completionDate":"2022-11-29"},{"nctId":"NCT05548270","phase":"PHASE3","title":"Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion","status":"COMPLETED","sponsor":"Repurposed Therapeutics, Inc.","startDate":"2022-08-23","conditions":["Motion Sickness"],"enrollment":503,"completionDate":"2022-11-29"},{"nctId":"NCT04785118","phase":"PHASE4","title":"Hyoscine Butyl-bromide Versus Ondansetron for Nausea and Vomiting During Cesarean Section Under Spinal Anesthesia","status":"COMPLETED","sponsor":"Assiut University","startDate":"2021-10-01","conditions":["Vomiting"],"enrollment":165,"completionDate":"2022-12-12"},{"nctId":"NCT02960113","phase":"PHASE4","title":"Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean Section","status":"COMPLETED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2016-05","conditions":["Nausea","Vomiting","Satisfaction"],"enrollment":240,"completionDate":"2021-09"},{"nctId":"NCT03961165","phase":"PHASE3","title":"BUSCLAB - Buscopan to Prevent Slow Progress in Labor","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2019-05-25","conditions":["Labor (Obstetrics)--Complications","Labor; Prolonged, First Stage"],"enrollment":250,"completionDate":"2022-06-16"},{"nctId":"NCT03541408","phase":"NA","title":"Preventative Delirium Protocol in Elderly Patients","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2016-05-01","conditions":["Delirium"],"enrollment":263,"completionDate":"2021-04-01"},{"nctId":"NCT04866355","phase":"NA","title":"Lumbar Spine Manipulation Versus Pharmacological Therapy in Young Women With Primary Dysmenorrhea","status":"COMPLETED","sponsor":"University of Alcala","startDate":"2021-02-28","conditions":["Women With Primary Dysmenorrhea"],"enrollment":42,"completionDate":"2022-11-10"},{"nctId":"NCT02812862","phase":"PHASE4","title":"Cardiac Effects of Spiolto®/Respimat® in Patients With Congestive Heart Failure and COPD","status":"WITHDRAWN","sponsor":"RWTH Aachen University","startDate":"2016-08","conditions":["COPD"],"enrollment":0,"completionDate":"2018-08"},{"nctId":"NCT03842839","phase":"NA","title":"Effect of Tiotropium on Airway Remodeling in Patients With Early Stage COPD Accessed by Optical Coherence Tomography","status":"UNKNOWN","sponsor":"Guangzhou Institute of Respiratory Disease","startDate":"2018-10-01","conditions":["Airway Remodeling"],"enrollment":100,"completionDate":"2022-12"},{"nctId":"NCT05375721","phase":"NA","title":"Prevention of PONV With Traditional Chinese Medicine","status":"UNKNOWN","sponsor":"The Second Hospital of Anhui Medical University","startDate":"2022-09-23","conditions":["Postoperative Nausea and Vomiting"],"enrollment":300,"completionDate":"2024-05-01"},{"nctId":"NCT04008264","phase":"","title":"A Novel Usage of Transdermal Scopolamine in Reducing Narcotic Usage in Outpatient Hand Surgery","status":"COMPLETED","sponsor":"Alexander M Spiess, MD","startDate":"2019-06-25","conditions":["Post Operative Pain Management"],"enrollment":74,"completionDate":"2022-07-01"},{"nctId":"NCT00662792","phase":"PHASE3","title":"Efficacy and Safety Comparison of Tiotropium Daily + Salmeterol Daily or Twice Daily Versus Tiotropium Daily in Patients With COPD","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2008-04-15","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":147,"completionDate":"2009-07-22"},{"nctId":"NCT04249310","phase":"","title":"Early Intervention Efficacy in COPD","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2020-03-27","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":6788,"completionDate":"2020-08-12"},{"nctId":"NCT05113615","phase":"PHASE4","title":"Regular Use Tiotropium and Tolerance to Bronchoprotection in Mild Asthma","status":"COMPLETED","sponsor":"University of Saskatchewan","startDate":"2021-12-13","conditions":["Asthma"],"enrollment":12,"completionDate":"2022-05-06"},{"nctId":"NCT00932737","phase":"PHASE2","title":"(Hyoscine Butylbromide) for Abdominal Pain Associated With Cramping on Demand Basis","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2009-06-09","conditions":["Abdominal Pain"],"enrollment":197,"completionDate":"2010-02-08"},{"nctId":"NCT04349722","phase":"PHASE4","title":"The Effect of Hyoscine-N-butylbromide (HBB, Buscopan) in Augmented Labour Among Primigravidae","status":"COMPLETED","sponsor":"National University of Malaysia","startDate":"2019-12-01","conditions":["Labor Long"],"enrollment":110,"completionDate":"2020-06-30"},{"nctId":"NCT03083067","phase":"NA","title":"Salvational Intervention for Reducing AECOPD Under Severe Air Pollution","status":"COMPLETED","sponsor":"Peking University First Hospital","startDate":"2017-03-20","conditions":["COPD Exacerbation","Air Pollution"],"enrollment":402,"completionDate":"2022-03-16"},{"nctId":"NCT02864407","phase":"","title":"Vahelva Respimat Regulatory Post-marketing Surveillance in Korean Patients With Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2016-12-19","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":3223,"completionDate":"2021-01-20"},{"nctId":"NCT03055390","phase":"PHASE4","title":"Effect of Intravenous Hyoscine Butylbromide Injection on Labour in High Risk Women","status":"COMPLETED","sponsor":"Cairo University","startDate":"2017-02-11","conditions":["Vaginal Delivery"],"enrollment":300,"completionDate":"2022-02-03"},{"nctId":"NCT02518139","phase":"PHASE3","title":"A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Mylan Inc.","startDate":"2015-09","conditions":["Chronic Obstructive Pulmonary Disease (COPD)"],"enrollment":1060,"completionDate":"2017-06"},{"nctId":"NCT03095456","phase":"PHASE3","title":"Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD","status":"COMPLETED","sponsor":"Mylan Inc.","startDate":"2017-03-27","conditions":["Chronic Obstructive Pulmonary Disease, COPD","Low Peak Inspiratory Flow Rate (PIFR)"],"enrollment":207,"completionDate":"2017-11-25"},{"nctId":"NCT05222646","phase":"PHASE1","title":"Metoclopramide Versus Hyoscine Butylbromide in Shortening Duration of First Stage of Labour","status":"UNKNOWN","sponsor":"Uwakwe Emmanuel Chijioke","startDate":"2022-01-03","conditions":["Duration of Labour"],"enrollment":150,"completionDate":"2022-08-30"},{"nctId":"NCT03513250","phase":"NA","title":"Efficacy of Hyoscine-n-butylbromide in Catheter-related Bladder Discomfort After Elective Cesarean Section.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2018-05-30","conditions":["Catheter Related Bladder Discomfort"],"enrollment":92,"completionDate":"2020-07-15"},{"nctId":"NCT04682860","phase":"PHASE4","title":"Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2021-09-08","conditions":["Acute Gastroenteritis","Abdominal Pain"],"enrollment":50,"completionDate":"2022-01-03"},{"nctId":"NCT02824679","phase":"PHASE4","title":"Effect of Intravenous Hyoscine Butylbromide Injection on First Stage Labour in Primigavidae","status":"COMPLETED","sponsor":"Ahmed M Maged, MD","startDate":"2015-07","conditions":["Vaginal Delivery"],"enrollment":200,"completionDate":"2017-03"},{"nctId":"NCT03979807","phase":"","title":"A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2019-06-10","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":11296,"completionDate":"2019-06-11"},{"nctId":"NCT04926233","phase":"","title":"Characteristics and Treatment Patterns of Patients With Chronic Obstructive Pulmonary Disease (COPD), Initiating Tio+Olo or Other Maintenance Therapies in the US and the UK: A Retrospective Claims Database Study","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2019-11-15","conditions":["Pulmonary Disease, Chronic Obstructive"],"enrollment":1371146,"completionDate":"2020-04-14"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"003459","UNII":"2Z3E1OF81V","CHEBI":"CHEBI:32123","RXNORM":"1085787","UMLSCUI":"C0006519","chemblId":"CHEMBL1618102","ChEMBL_ID":"CHEMBL1256901","DRUGBANK_ID":"DB09300","PUBCHEM_CID":"6852391","SNOMEDCT_US":"1156229000","SECONDARY_CAS_RN":"149-64-4","MESH_DESCRIPTOR_UI":"D002086"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"1%"},"publicationCount":85,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"A03BB01","allCodes":["A03BB01","A03DB04"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"OTHER","regulator":"YEAR INTRODUCED","status":"approved","approval_date":"1951-01-01T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:56:50.837852+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}